Suchergebnisse - "Pinato, David J"

PubPharm (10)

1

Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinoma

enthalten in: JHEP reports : innovation in hepatology | 2023

von Pinato, D. | Kaneko, T. | D'Alessio, A. | +21

2

Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancer

enthalten in: Cancer treatment reviews | 2022

von Schettini, F. | Venturini, S. | Giuliano, M. | +27

3

Predictive biomarkers of response to immune checkpoint inhibitors in hepatocellular carcinoma

enthalten in: Expert review of molecular diagnostics | 2022

von Muhammed, A. | D'Alessio, A. | Enica, A. | +6

4

Post-progression outcomes of NSCLC patients with PD-L1 expression ≥ 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Cortellini, A. | Cannita, K. | Tiseo, M. | +49

CommentIn: Eur J Cancer. 2021 Sep;155:294-295. - PMID 34364743

5

PRIME-HCC : phase Ib study of neoadjuvant ipilimumab and nivolumab prior to liver resection for hepatocellular carcinoma

enthalten in: BMC cancer | 2021

von Pinato, D. | Cortellini, A. | Sukumaran, A. | +14

6

PRIME-HCC: phase Ib study of neoadjuvant ipilimumab and nivolumab prior to liver resection for hepatocellular carcinoma

enthalten in: BMC cancer | 2021

von Pinato, D. | Cortellini, A. | Sukumaran, A. | +14

7

Programmed Cell Death Ligand Expression Drives Immune Tolerogenesis across the Diverse Subtypes of Neuroendocrine Tumours

enthalten in: Neuroendocrinology | 2021

von Pinato, D. | Vallipuram, A. | Evans, J. | +9

8

Programmed death ligand 1 (PD-L1) expression influences the immune-tolerogenic microenvironment in antiretroviral therapy-refractory Kaposi's sarcoma : A pilot study

enthalten in: Oncoimmunology | 2017

von Mletzko, S. | Pinato, D. | Robey, R. | +4

9

Programmed cell death ligands expression in phaeochromocytomas and paragangliomas : Relationship with the hypoxic response, immune evasion and malignant behavior

enthalten in: Oncoimmunology | 2017

von Pinato, D. | Black, J. | Trousil, S. | +4

10

Intra-tumoral heterogeneity in the expression of programmed-death (PD) ligands in isogeneic primary and metastatic lung cancer : Implications for immunotherapy

enthalten in: Oncoimmunology | 2016

von Pinato, D. | Shiner, R. | White, S. | +5

1
[1]